PAVmed Inc. — Director's Dealing 2017

Aug 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2017-08-03

Reporting Person: Battleman David S. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-03	Stock Option (right to buy)	$2.98	A	40000	Acquired	2027-08-02	Common Stock (40000)	Direct

Footnotes

F1: The option shall become exercisable as to one-twelfth (1/12) of the option shares on September 30, 2017, and shall become exercisable as to one-twelfth (1/12) of the option shares on the last day of each successive fiscal quarter for the following eleven (11) fiscal quarters.